Concepts (280)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gluconeogenesis | 14 | 2024 | 96 | 2.310 |
Why?
|
| Insulin Resistance | 16 | 2023 | 698 | 1.520 |
Why?
|
| Glucose | 17 | 2024 | 871 | 1.360 |
Why?
|
| Lipodystrophy | 4 | 2023 | 33 | 0.580 |
Why?
|
| Energy Metabolism | 4 | 2024 | 784 | 0.560 |
Why?
|
| Insulin | 11 | 2023 | 1168 | 0.550 |
Why?
|
| Glycogenolysis | 3 | 2018 | 10 | 0.530 |
Why?
|
| Blood Glucose | 16 | 2024 | 1121 | 0.490 |
Why?
|
| Parenteral Nutrition, Total | 3 | 2011 | 111 | 0.480 |
Why?
|
| Bile Acids and Salts | 4 | 2022 | 255 | 0.460 |
Why?
|
| Parenteral Nutrition | 6 | 2022 | 199 | 0.450 |
Why?
|
| Infant, Premature | 4 | 2023 | 843 | 0.420 |
Why?
|
| Digestion | 3 | 2020 | 44 | 0.400 |
Why?
|
| Fat Emulsions, Intravenous | 4 | 2021 | 79 | 0.400 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2024 | 1418 | 0.380 |
Why?
|
| Hyperglycemia | 4 | 2018 | 235 | 0.380 |
Why?
|
| Glycine | 4 | 2024 | 162 | 0.370 |
Why?
|
| Ghrelin | 1 | 2012 | 56 | 0.370 |
Why?
|
| Bariatric Surgery | 2 | 2024 | 139 | 0.350 |
Why?
|
| Metformin | 2 | 2024 | 166 | 0.330 |
Why?
|
| Cholestasis | 3 | 2021 | 157 | 0.330 |
Why?
|
| Deuterium Oxide | 2 | 2020 | 17 | 0.320 |
Why?
|
| Fasting | 4 | 2022 | 302 | 0.310 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2020 | 75 | 0.310 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2010 | 168 | 0.300 |
Why?
|
| Fatty Acids | 3 | 2020 | 356 | 0.300 |
Why?
|
| Obesity, Morbid | 2 | 2022 | 211 | 0.300 |
Why?
|
| Methionine | 4 | 2011 | 102 | 0.300 |
Why?
|
| Glucose Intolerance | 2 | 2022 | 85 | 0.290 |
Why?
|
| Starch | 3 | 2020 | 26 | 0.280 |
Why?
|
| Liver Diseases | 3 | 2019 | 385 | 0.280 |
Why?
|
| Premature Birth | 3 | 2022 | 418 | 0.280 |
Why?
|
| alpha-Glucosidases | 2 | 2020 | 31 | 0.270 |
Why?
|
| Vitamin E | 2 | 2019 | 63 | 0.270 |
Why?
|
| Liver | 6 | 2021 | 1797 | 0.260 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 382 | 0.250 |
Why?
|
| Soybean Oil | 4 | 2021 | 70 | 0.250 |
Why?
|
| Sucrase-Isomaltase Complex | 2 | 2017 | 19 | 0.240 |
Why?
|
| Carbon Isotopes | 5 | 2020 | 233 | 0.240 |
Why?
|
| Animals, Newborn | 6 | 2023 | 1033 | 0.230 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2024 | 14 | 0.220 |
Why?
|
| Dietary Carbohydrates | 2 | 2016 | 108 | 0.220 |
Why?
|
| Benzoic Acid | 1 | 2024 | 3 | 0.220 |
Why?
|
| Thermogenesis | 1 | 2024 | 51 | 0.220 |
Why?
|
| Enteral Nutrition | 3 | 2023 | 267 | 0.210 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 87 | 0.210 |
Why?
|
| Adipose Tissue, White | 1 | 2024 | 94 | 0.210 |
Why?
|
| Phytosterols | 2 | 2021 | 28 | 0.200 |
Why?
|
| Swine | 6 | 2023 | 1179 | 0.200 |
Why?
|
| Steroid 12-alpha-Hydroxylase | 1 | 2022 | 5 | 0.200 |
Why?
|
| Leptin | 2 | 2023 | 219 | 0.200 |
Why?
|
| Glutathione | 3 | 2021 | 200 | 0.190 |
Why?
|
| Hypoglycemic Agents | 3 | 2024 | 482 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 4758 | 0.190 |
Why?
|
| Adipose Tissue | 3 | 2020 | 510 | 0.180 |
Why?
|
| Sus scrofa | 4 | 2019 | 121 | 0.180 |
Why?
|
| Animals | 21 | 2024 | 34850 | 0.180 |
Why?
|
| Exercise | 2 | 2019 | 860 | 0.180 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2022 | 75 | 0.170 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2020 | 74 | 0.170 |
Why?
|
| Aging | 3 | 2024 | 1254 | 0.170 |
Why?
|
| Muscle Strength | 1 | 2021 | 86 | 0.170 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2018 | 116 | 0.160 |
Why?
|
| Incretins | 1 | 2020 | 25 | 0.160 |
Why?
|
| Acetylcysteine | 1 | 2021 | 82 | 0.160 |
Why?
|
| Receptor, Insulin | 1 | 2020 | 68 | 0.160 |
Why?
|
| Lipolysis | 1 | 2020 | 75 | 0.160 |
Why?
|
| Lipogenesis | 1 | 2020 | 60 | 0.160 |
Why?
|
| Male | 24 | 2024 | 65012 | 0.160 |
Why?
|
| Oxidation-Reduction | 6 | 2020 | 436 | 0.160 |
Why?
|
| Homeostasis | 2 | 2021 | 722 | 0.160 |
Why?
|
| Gastrectomy | 1 | 2020 | 102 | 0.160 |
Why?
|
| Barth Syndrome | 1 | 2019 | 1 | 0.150 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 325 | 0.150 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2010 | 67 | 0.150 |
Why?
|
| Phospholipids | 1 | 2019 | 104 | 0.150 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2011 | 176 | 0.150 |
Why?
|
| Humans | 34 | 2024 | 132247 | 0.150 |
Why?
|
| Rifampin | 1 | 2019 | 120 | 0.150 |
Why?
|
| Female | 25 | 2024 | 70785 | 0.150 |
Why?
|
| Alanine | 3 | 2023 | 159 | 0.150 |
Why?
|
| Fatty Liver | 1 | 2020 | 211 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2020 | 436 | 0.140 |
Why?
|
| Dietary Supplements | 2 | 2021 | 439 | 0.140 |
Why?
|
| Proglucagon | 1 | 2017 | 5 | 0.140 |
Why?
|
| Glucan 1,4-alpha-Glucosidase | 1 | 2017 | 5 | 0.140 |
Why?
|
| Glucagon | 3 | 2017 | 151 | 0.140 |
Why?
|
| Sucrase | 1 | 2017 | 23 | 0.140 |
Why?
|
| Infant, Newborn | 6 | 2023 | 8548 | 0.140 |
Why?
|
| Homocysteine | 4 | 2011 | 120 | 0.140 |
Why?
|
| Intestines | 1 | 2021 | 606 | 0.140 |
Why?
|
| Isothiocyanates | 1 | 2017 | 11 | 0.140 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2017 | 39 | 0.130 |
Why?
|
| Gastrointestinal Agents | 1 | 2017 | 64 | 0.130 |
Why?
|
| Leucine | 3 | 2023 | 260 | 0.130 |
Why?
|
| Bicycling | 1 | 2016 | 35 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2021 | 801 | 0.120 |
Why?
|
| Cognition | 1 | 2021 | 811 | 0.120 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2016 | 50 | 0.120 |
Why?
|
| Thinness | 1 | 2016 | 74 | 0.120 |
Why?
|
| Models, Biological | 3 | 2016 | 1445 | 0.120 |
Why?
|
| Adult | 14 | 2022 | 31614 | 0.120 |
Why?
|
| Serine | 1 | 2016 | 166 | 0.110 |
Why?
|
| Inflammation | 2 | 2021 | 1522 | 0.110 |
Why?
|
| Diet, Protein-Restricted | 1 | 2016 | 82 | 0.110 |
Why?
|
| Microbiota | 1 | 2020 | 434 | 0.110 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 255 | 0.110 |
Why?
|
| Mice | 8 | 2024 | 18507 | 0.110 |
Why?
|
| Swine Diseases | 1 | 2014 | 42 | 0.110 |
Why?
|
| Calorimetry, Indirect | 3 | 2021 | 61 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 240 | 0.100 |
Why?
|
| Amino Acids | 3 | 2023 | 626 | 0.100 |
Why?
|
| Fish Oils | 3 | 2021 | 80 | 0.100 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2023 | 167 | 0.100 |
Why?
|
| Food Deprivation | 1 | 2012 | 34 | 0.090 |
Why?
|
| Receptors, Ghrelin | 1 | 2012 | 30 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 663 | 0.090 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 2011 | 5 | 0.090 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2011 | 44 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 92 | 0.090 |
Why?
|
| Muscle, Skeletal | 3 | 2023 | 1037 | 0.090 |
Why?
|
| Young Adult | 6 | 2021 | 9966 | 0.080 |
Why?
|
| Emulsions | 2 | 2021 | 70 | 0.080 |
Why?
|
| Gestational Age | 2 | 2015 | 1227 | 0.080 |
Why?
|
| Adolescent | 8 | 2024 | 20557 | 0.080 |
Why?
|
| Hydrocortisone | 1 | 2011 | 226 | 0.080 |
Why?
|
| Isotope Labeling | 3 | 2020 | 92 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2024 | 3414 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2015 | 554 | 0.080 |
Why?
|
| Colitis | 1 | 2011 | 165 | 0.080 |
Why?
|
| Amino Acids, Sulfur | 1 | 2009 | 15 | 0.080 |
Why?
|
| Craniosynostoses | 1 | 2011 | 130 | 0.080 |
Why?
|
| Abdomen | 1 | 2009 | 135 | 0.070 |
Why?
|
| Birth Weight | 1 | 2010 | 351 | 0.070 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 2 | 2021 | 34 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 666 | 0.070 |
Why?
|
| Intestinal Mucosa | 2 | 2013 | 797 | 0.070 |
Why?
|
| Methenamine | 1 | 2008 | 7 | 0.070 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 464 | 0.070 |
Why?
|
| Lactation | 1 | 2009 | 198 | 0.070 |
Why?
|
| Body Water | 1 | 2008 | 88 | 0.070 |
Why?
|
| Glucose Tolerance Test | 2 | 2018 | 206 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2013 | 3868 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 3761 | 0.070 |
Why?
|
| Radioactive Tracers | 1 | 2006 | 20 | 0.060 |
Why?
|
| Blood Specimen Collection | 1 | 2006 | 47 | 0.060 |
Why?
|
| Obesity | 3 | 2024 | 2398 | 0.060 |
Why?
|
| Critical Illness | 1 | 2009 | 618 | 0.060 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2024 | 6 | 0.060 |
Why?
|
| Dioxoles | 1 | 2024 | 12 | 0.060 |
Why?
|
| Uncoupling Protein 1 | 1 | 2024 | 32 | 0.060 |
Why?
|
| Mitochondria | 2 | 2021 | 751 | 0.060 |
Why?
|
| Triglycerides | 2 | 2020 | 617 | 0.060 |
Why?
|
| Gastrointestinal Tract | 1 | 2007 | 232 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2009 | 906 | 0.050 |
Why?
|
| Hippurates | 1 | 2024 | 7 | 0.050 |
Why?
|
| Liraglutide | 1 | 2024 | 15 | 0.050 |
Why?
|
| Pregnancy | 4 | 2021 | 7557 | 0.050 |
Why?
|
| Biomarkers | 3 | 2021 | 3404 | 0.050 |
Why?
|
| Palmitates | 1 | 2023 | 17 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2022 | 1700 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 3018 | 0.050 |
Why?
|
| Glycerol | 1 | 2023 | 82 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1175 | 0.050 |
Why?
|
| Child | 6 | 2021 | 25783 | 0.050 |
Why?
|
| Carbon | 1 | 2023 | 94 | 0.050 |
Why?
|
| Lactic Acid | 1 | 2023 | 154 | 0.050 |
Why?
|
| Cholic Acid | 1 | 2022 | 19 | 0.050 |
Why?
|
| Diet | 3 | 2020 | 1125 | 0.050 |
Why?
|
| Glycine Agents | 1 | 2021 | 10 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2022 | 268 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2021 | 58 | 0.040 |
Why?
|
| Endothelium | 1 | 2021 | 64 | 0.040 |
Why?
|
| Keto Acids | 1 | 2020 | 50 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2012 | 326 | 0.040 |
Why?
|
| Peptide YY | 1 | 2020 | 19 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 165 | 0.040 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2020 | 19 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 2012 | 547 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2012 | 3139 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 446 | 0.040 |
Why?
|
| Middle Aged | 4 | 2021 | 29021 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 192 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 584 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2022 | 404 | 0.040 |
Why?
|
| Hyperbilirubinemia | 1 | 2019 | 42 | 0.040 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2019 | 50 | 0.040 |
Why?
|
| Glucuronosyltransferase | 1 | 2019 | 62 | 0.040 |
Why?
|
| Palmitic Acid | 1 | 2018 | 29 | 0.040 |
Why?
|
| Amino Acids, Essential | 1 | 2018 | 22 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 437 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2021 | 417 | 0.040 |
Why?
|
| Tritium | 2 | 2009 | 112 | 0.040 |
Why?
|
| Glucose Clamp Technique | 1 | 2018 | 75 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2021 | 4720 | 0.040 |
Why?
|
| Exercise Test | 1 | 2019 | 256 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 1285 | 0.040 |
Why?
|
| Gene Expression | 2 | 2014 | 1563 | 0.030 |
Why?
|
| Shrews | 1 | 2017 | 5 | 0.030 |
Why?
|
| DNA Damage | 1 | 2021 | 511 | 0.030 |
Why?
|
| Methylation | 2 | 2009 | 208 | 0.030 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2017 | 40 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 2017 | 31 | 0.030 |
Why?
|
| Sulfoxides | 1 | 2017 | 10 | 0.030 |
Why?
|
| India | 1 | 2018 | 238 | 0.030 |
Why?
|
| Kinetics | 2 | 2009 | 1130 | 0.030 |
Why?
|
| China | 1 | 2018 | 290 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2018 | 209 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2021 | 1444 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 431 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2017 | 118 | 0.030 |
Why?
|
| Glycogen | 1 | 2016 | 53 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 341 | 0.030 |
Why?
|
| Body Fat Distribution | 1 | 2016 | 32 | 0.030 |
Why?
|
| Energy Intake | 1 | 2018 | 493 | 0.030 |
Why?
|
| Athletes | 1 | 2016 | 73 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 124 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2016 | 124 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2017 | 699 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 329 | 0.030 |
Why?
|
| Cholestenones | 1 | 2014 | 7 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2923 | 0.030 |
Why?
|
| Olive Oil | 1 | 2014 | 24 | 0.030 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2014 | 47 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 469 | 0.030 |
Why?
|
| Plant Oils | 1 | 2014 | 34 | 0.030 |
Why?
|
| Postprandial Period | 1 | 2013 | 91 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1126 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 6568 | 0.020 |
Why?
|
| Algorithms | 2 | 2009 | 1725 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 2724 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5176 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 926 | 0.020 |
Why?
|
| Sex Factors | 1 | 2016 | 1354 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2451 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 1080 | 0.020 |
Why?
|
| Pyridoxal Phosphate | 1 | 2011 | 12 | 0.020 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2011 | 16 | 0.020 |
Why?
|
| Infant | 3 | 2012 | 13049 | 0.020 |
Why?
|
| Methylmalonic Acid | 1 | 2011 | 15 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2013 | 309 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 2011 | 47 | 0.020 |
Why?
|
| Peroxidase | 1 | 2011 | 64 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 561 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2011 | 188 | 0.020 |
Why?
|
| Hexoses | 1 | 2009 | 11 | 0.020 |
Why?
|
| Ketone Bodies | 1 | 2009 | 38 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 7138 | 0.020 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2009 | 4 | 0.020 |
Why?
|
| Lactates | 1 | 2009 | 86 | 0.020 |
Why?
|
| Nitrogen Isotopes | 1 | 2009 | 46 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1008 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 2009 | 75 | 0.020 |
Why?
|
| C-Peptide | 1 | 2009 | 109 | 0.020 |
Why?
|
| Kidney | 1 | 2015 | 1338 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4690 | 0.020 |
Why?
|
| Cysteine | 1 | 2009 | 142 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2009 | 275 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 1128 | 0.020 |
Why?
|
| Goblet Cells | 1 | 2009 | 107 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 3046 | 0.020 |
Why?
|
| Organ Size | 1 | 2009 | 447 | 0.020 |
Why?
|
| Cell Division | 1 | 2009 | 744 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 2012 | 0.020 |
Why?
|
| Sulfur Compounds | 1 | 2007 | 5 | 0.020 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2007 | 14 | 0.020 |
Why?
|
| Metabolomics | 1 | 2011 | 479 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 995 | 0.020 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2006 | 38 | 0.020 |
Why?
|
| Capillaries | 1 | 2006 | 71 | 0.020 |
Why?
|
| Milk, Human | 1 | 2009 | 308 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 881 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 636 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2012 | 14736 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3853 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 3093 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 21482 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 6451 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 13027 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 6250 | 0.010 |
Why?
|